<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03204409</url>
  </required_header>
  <id_info>
    <org_study_id>734548NH (EC | H2020 | RIA)</org_study_id>
    <nct_id>NCT03204409</nct_id>
  </id_info>
  <brief_title>ZIKAlliance Natural History Study</brief_title>
  <acronym>ZIKAllianceNH</acronym>
  <official_title>Longitudinal Clinical and Virological Study Among Symptomatic Patients With Zika Virus Infection in the City of Sao Paulo, Brazil</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Heidelberg Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Heidelberg Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study to enroll up to 1000 adult patients (&gt;18 years) presenting with febrile or rash illness
      of short duration (&lt;72h) in designated clinics in the State of Sao Paulo, Brazil.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Study to enroll up to 1000 adult patients (&gt;18 years) presenting with febrile or rash
           illness of short duration (&lt;72h) in designated clinics in the State of Sao Paulo,
           Brazil.

        -  Following enrolment (day 0), patients will be followed up at days 2-3, 7, 14, 21, 30,
           90, 180 and 360 with clinical and biological procedures (blood and urine samples).

        -  For patients with proven ZIKA Virus (ZIKV) infection, follow-up samples will include
           blood, saliva, urine and genital samples.

        -  For non-ZIKV infected patients, follow-up samples will include serological monitoring at
           days 14, 30, 180 and 360, and for men, possible assessment of genital fluids at day 180.

        -  All patients will be evaluated for impact on disability up to one year. Household adult
           contacts of ZIKV patients will be invited for ZIKV evaluation including collection of
           blood and urine samples.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2017</start_date>
  <completion_date type="Anticipated">September 3, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>ZIKA Virus Infection</measure>
    <time_frame>up to one year</time_frame>
    <description>Clinical Characterization</description>
  </primary_outcome>
  <primary_outcome>
    <measure>DENGUE Virus Infection</measure>
    <time_frame>up to one year</time_frame>
    <description>Clinical Characterization</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Chikungunya Virus Infection</measure>
    <time_frame>up to one year</time_frame>
    <description>Clinical Characterization</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Zika Virus</condition>
  <condition>Zika Virus Infection</condition>
  <arm_group>
    <arm_group_label>Symptomatic adults</arm_group_label>
    <description>adult patients (&gt;18 years) presenting with febrile or rash illness of short duration (&lt;72h)</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood, saliva, urine and genital fluid samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        General Population
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Rash or Fever illness

          -  within 72 hours of symptom onset

        Exclusion Criteria:

          -  presence of symptoms or complications indicative of a bacterial infection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Jänisch</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Heidelberg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thomas Jänisch</last_name>
    <phone>+49 6221 56 38040</phone>
    <email>thomas.jaenisch@urz.uni-heidelberg.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Sao Paulo</name>
      <address>
        <city>São Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vivian Avelino-Silva</last_name>
      <email>vivian87@usp.br</email>
    </contact>
    <contact_backup>
      <last_name>Aluisio Cotrim Segurado</last_name>
      <email>segurado@usp.br</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 29, 2017</study_first_submitted>
  <study_first_submitted_qc>June 29, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 2, 2017</study_first_posted>
  <last_update_submitted>June 30, 2017</last_update_submitted>
  <last_update_submitted_qc>June 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Heidelberg Medical Center</investigator_affiliation>
    <investigator_full_name>Thomas Jaenisch</investigator_full_name>
    <investigator_title>Senior Scientist</investigator_title>
  </responsible_party>
  <keyword>CHIKV</keyword>
  <keyword>DENGUE</keyword>
  <keyword>Chikungunya</keyword>
  <keyword>DENV</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Virus Diseases</mesh_term>
    <mesh_term>Zika Virus Infection</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

